Abstract
Many threads link the study of MT to medicine and pathology. After all, the most specific of MT poisons, colchicine, has been used for centuries in the treatment of gout, and the discovery by Pernice in 1889 [90] of its action on mitosis was the result of studies on its toxicity. The other specific MT poisons, VLB and VCR, have become routinely used, with excellent results, in the treatment of many malignant conditions in man. Last, griseofulvin, used as a fungistatic, also belongs to the group of drugs modifying MT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, M., Warr, J. R.: Colchicine-resistant mutants of Chlamydomonas rheinhardii. Exp. Cell Res. 71, 473–475 (1972)
Aizelius, B. A., Eliasson, R., Johnsen, Ø., Lindholmer, C.: Lack of dynein arms in immotile human spermatozoa. J. Cell Biol. 66, 225–232 (1975)
Ahn, Y. S., Harrington, W. J., Seelman, R. O., Eytel, C. S.: Vincristine therapy of idiopathic and secondary thrombocytosis. New Engl. J. Med. 291, 376–380 (1974)
Aisner, J., Weiss, H. D., Chang, P., Wiernik, P. H.: Orthostatic hypotension during combination chemotherapy with vincristine (NSC-67574). Cancer Chemother. Rep. 58, 927–930 (1974)
Alarcon-Segovia, D., Ibanez, G., Kerchenobich, D., Rojkind, M.: Treatment of scleroderma by modification of collagen metabolism. A double blind trial with colchicine-placebo. J. Rheumatol. 1 (Suppl.), 97 (1974)
Armstrong, J. G.: Vincristine (NSC-67574) symposium. Summary and prospectives. Cancer Chemother. Rep. 52, 527–535 (1968)
Bandmann, U., Norberg, B., Simmingsköld, G.: Griseofulvin inhibition of polymorphonuclear leucocyte chemotaxis in Boyden chambers. Scand. J. Haemat. 15, 81–87 (1975)
Bartter, F. C., Schwartz, W. B.: The syndrome of inappropriate secretion of antidiuretic hormone. Am. J. Med. 42, 790–806 (1967)
Boxer, L. A., Rister, M., Allen, J. M., Baehner, R. L.: Improvement of Chediak-Higashi leukocyte function by cychc guanosine monophosphate. Blood 49, 9–17 (1977)
Bradley, W. G., Lassman, L. P., Pearce, G. W., Walton, J. N.: The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J. Neurol. Sci. 10, 107–132 (1970)
Bremmer, W. J., Paulsen, C. A.: Colchicine and testicular function in Man. New Engl. J. Med. 294, 1384–1385 (1976)
Brinkley, B. R., Fuller, G. M., Highfield, D. P.: Cytoplasmic microtubules in normal and transformed cells in culture. Analysis by tubulin antibody immunofluorescence. Proc. Natl. Acad. Sci. USA 72, 4981–4985 (1975)
Brinkley, B. R., Miller, C. L., Fuseler, J. W., Pepper, D. A., Wible, L. J.: The cytoskeleton and cell transformation in malignancy. Microtubules, microfilaments, and growth properties in vitro. Cancer Bull. 29, 13–15 (1977)
Brune, K., Bucher, K. E. Walz, D.: The avian microcrystal arthritis. II. Central versus peripheral effects of sodium salicylate, acetaminophen and colchicine. Agents and Actions 4, 27–33 (1974)
Brune, K., Glatt, M.: The avian microcrystal arthritis. III. Invasion and enzyme-release from leukocytes at the site of inflammation. Agents and Actions 4, 95–100 (1974)
Brune, K., Glatt, M.: The avian microcrystal arthritis. IV. The impact of sodium salicylate, acetaminophen and colchicine on leukocyte invasion and enzyme liberation in vivo. Agents and Actions 4, 101–107 (1974)
Brune, K., Graf, P., Glatt, M.: Anti-inflammatory action of colchicine. In: Microtubules and Microtubule Inhibitors (eds.: M. Borgers, M. De Brabander), pp. 471–481. Amsterdam-Oxford: North-Holland 1975
Byers, P. H., Ward, P. A., Kellermeyer, R. W., Naff, G. B.: Complement as a mediator of inflammation in acute gouty arthritis. II. Biological activities generated from complement by the interaction of serum complement and sodium urate crystals. J. Lab. Clin. Med. 81, 761–769 (1973)
Caner, J. E. Z.: Colchicine inhibition of chemotaxis. Arthritis Rheum. 8, 757–764 (1965)
Carmichael, S. M., Eagleton, L., Ayers, C. R.: Orthostatic hypotension during vincristine therapy. Arch. Intern. Med. 126, 290–293 (1970)
Casey, E. B., Jeliffe, A. M., Le Quesne, P. M., Millett, Y. L.: Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96, 69–86 (1973)
Castaing, R., Boget, J. C., Favarel-Garrigues, J. C., Vital, C., Cardinaud, J. P.: Intoxication aiguë mortelle par la colchicine. Bordeaux Méd. 2101–2104 (1968)
Chédiak, M.: Nouvelle anomalie leucocytaire de caractère constitutionel et familial. Rev. Hématol. (Paris) 7, 352–357 (1952)
Choi, S., Simone, J. V., Edwards, C. C.: Effects of vincristine on platelet production. In: Platelets. Production, Function, Transfusion and Storage (eds.: M. G. Baldini, S. H. Ebbe), pp. 51–62. New York: Grune and Stratton 1974
Cutting, H. O.: Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am. J. Med. 51, 269–271 (1971)
Denko, C. W.: Anti-prostaglandin action of colchicine. Pharmacology 13, 219–227 (1975)
D’Agostino, A. N., Jarcho, L. W.: A new neuropathy associated with vincristine (leurocristine) therapy. Clin. Res. 12, 106 (1964)
Dinarello, C. A., Wolff, S. M., Goldfinger, S. E., Dale, D. C., Ailing, D. W.: Colchicine therapy for familial Mediterranean fever: a double-blind trial. New Engl. J. Med. 291, 934–937 (1974)
Dinarello, C. A, Chusid, M. J., Fauci, A. S. Gallin, J. I., Dale, D. C., Wolff, S. M.: Effect of prophylactive colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum. 19, 618–622 (1976)
Dittman, W. A., Ward, J. R.: Demecolcine toxicity. A case report of severe hematopoietic toxicity and a review of the literature. Am. J. Med. 27, 519–524 (1959)
Dustin, P.: Intoxication mortelle par la colchicine. Etude histologique et hématologique. Bull. Acad. Roy Méd. Belg. VIe. série 6, 505–529 (1941)
Ertel, N., Omokoku, B., Wallace, S. L.: Colchicine concentrations in leukocytes. Arthritis Rheum. 12, 293 (1969)
Ertel, N. H., Mittler, J. C., Akgun, S., Wallace, S. L.: Radioimmunoassay for colchicine in plasma and urine. Science 193, 233–234 (1976)
Fine, R. N., Clarke, R. R., Shore, N. A.: Hyponatremia and vincristine therapy. Am. J. Dis. Child. 112, 256–259 (1966)
Fine, R. E., Taylor, L.: Decreased actin and tubulin synthesis in 3T3 cells after transformation by SV40 virus. Exp. Cell Res. 102, 162–168 (1976)
Flavin, M., Slaughter, C.: Microtubule assembly and function in Chlamydomonas: inhibition of growth and flagellar regeneration by antitubulins and other drugs and isolation of resistant mutants. J. Bacteriol. 118, 59–120 (1974)
Floersheim, G. L., Brune, K., Seiler, K.: Colchicine in avian sodium urate and calcium pyrophosphate microcrystal arthritis. Agents and Actions 3, 20–23 (1973)
Freed, J. J., Ohlsson-Wilhelm, B. M.: Cultured haploid cells resistant to antitubulins. In: Microtubules and Microtubule Inhibitors (eds.: M. Borgers, M. De Brabander), pp. 367–378. Amsterdam-Oxford: North-Holland 1975
Gaskin, F., Gethner, J. S.: Characterization of the in vitro assembly of microtubules. In: Cell Motiliry (eds.: R. Goldman, T. Pollard, J. Rosenbaum), pp. 1109–1123. Cold Spring Harbor Lab. 1976
Gaskin, F., Litman, D. J., Cantor, C. R., Shelanski, M. L.: The formation of filamentous structures from iodinated neurotubules. J. Supramol. Struct. 3, 39–50 (1975)
Gaultier, M., Bismuth, C., Autret, A., Pillon, M.: Antidiurèse inappropriée après intoxication aiguë par la colchicine. Deux cas. Nouv. Presse Méd. 4, 31–32 (1975)
Gaultier, M., Bismuth, C., Conso, F.: L’aplasie médullaire de la colchicine. A propos de 20 cas. Sang and Toxiques 98, 75–85 (1977)
Gaultier, M., Kanfer, A., Bismuth, C.: Données actuelles sur l’intoxication aiguë par la colchicine. A propos de 23 observations. Ann. Méd. Intern. (Paris) 120, 605–618 (1969)
Gmachl, E. (ed.): Internationales Symposium Über die Anwendung der Vinca-alkaloide Velbe und Vincristin. Berlin-Wien: Urban und Schwarzenberg 1969
Goldfinger, S. E.: Colchicine for familial Mediterranean fever. New Engl. J. Med. 287, 1302 (1972)
Goldstein, R. C., Schwabe, A. D.: Prophylactic colchicine therapy in familial Mediterranean fever. Ann. Intern. Med. 81, 792–794 (1974)
Goodenough, U. W., St. Clair, H. S.: Bald-2: a mutation affecting the formation of doublet and triplet sets of microtubules in Chlamydomonas reinhardii. J. Cell Biol. 66, 480–491 (1975)
Gooneratne, B. W.: Massive generalized alopecia after poisoning by Gloriosa superba. Brit. Med. J. 5494, 1023–1024 (1966)
Haggard, M. E., Fernback, D. J., Holcomb, T. M., Sutow, W. W., Vietti, T. J., Windmiller, J.: Vincristine in acute leukemia of childhood. Cancer 22, 438–444 (1968)
Harris, E. D. Jr., Hoffman, G. S., Mc Guire, J. L., Strosberg, J. M.: Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma. Metabolism 24, 529–536 (1975)
Harris, E. D. Jr., Millis, M.: Treatment with colchicine of the periarticular inflammation associated with sarcoidosis: A need for continued appraisal. Arthritis Rheum. 14, 130–133 (1971)
Heaney, D., Derghazarian, C. B., Pintteo, G. F., Ali, M. A. M.: Massive colchicine overdose: a report on the toxicity. Am. J. Med. Sci. 271, 233–238 (1976)
Higashi, O.: Congenital gigantism of peroxidase granules. The first case ever reported of qualitative abnormity of peroxidase. Tohoku J. Exp. Med. 59, 315–332 (1953)
Hildebrand, J., Coërs, S.: Etude clinique, histologique et électrophysiologique des neuropathies associées au traitement par la vincristine. Europ. J. Cancer 1, 51–58 (1965)
Hirano, A.: Neurofibrillary changes in conditions related to Alzheimer’s disease. In: Alzheimer’s Disease and Related Conditions (eds.: G. E. W. Wolstenholme, M. O’Connor), pp. 185–201. London: Churchill 1970
Hirano, A., Zimmerman, H. M.: Some effects of vinblastine implantation in the cerebral white matter. Lab. Invest. 23, 358–367 (1970)
Hitzig, W. H.: Colchicum-Vergiftung bei einem Kleinkind. 2. Beobachtungen über Blut-bildungs-und Mitosestörungen. Acta Haematol. 21, 170–186 (1959)
Hwang, Y. F., Hamilton, H. E., Sheets, R. F.: Vinblastine-induced thrombocytosis. Lancet 2, 1075–1076 (1969)
Iqbal, K., Wisniewski, H. M., Grundke-Iqbal, I., Korthals, J. K., Terry, R. D.: Chemical pathology of neurofibrils. Neurofibrillary tangles of Alzheimer’s presenile-senile dementia. J. Histochem. Cytochem. 23, 563–569 (1975)
Johnson, I. S., Armstrong, J. G., Gorman, M., Burnett, J. P. Jr.: the Vinca alkaloids: a new class of oncolytic agents. Cancer Res. 23, 1390–1427 (1963)
Kaplan, H.: Further experiences with colchicine in the treatment of sarcoid arthritis. New Engl. J. Med. 268, 761–764 (1963)
Kedar, I., Ravid, M., Sohar, E., Garni, J.: Colchicine inhibition of casein-induced amyloidosis in mice. Israel J. Med. Sci. 10, 787–789 (1974)
Klener, P., Donner, L., Housková, J.: Thrombocytosis in rats induced by vinblastine. Haemostasis 1, 73–78 (1972)
Klener, P., Dormer, L., Hynčica, V., Šafránková, D.: Possible mechamism of vinblastine-induced thrombocytosis. Scand. J. Haematol. 12, 179–184 (1974)
Krisza, F., Kovacs, Z., Dobay, E.: Effect of vincristine on the megacaryocyte system in mice. J. Med. 4, 12–18 (1973)
Layani, F., Aschkenasy, A., Mouzon, M.: Intoxication aiguë par la colchicine; importantes altérations de la leucopoïèse. Bull. Soc. Méd. Hôp. Paris 63, 10–16 (1947)
Legard, C., Eberlin, A., Caen, J. P.: Vincristine-induced thrombocytosis in the rat. Thrombopoiesis and platelet populations. Path. Biol. 21, 41–45 (1973)
Loo, H., Zittoun, R.: Intoxication aiguë à forme comateuse par la vincristine. Gaz. Méd. Fr. 76, 2693–2698 (1969)
McCarty, D. J.: Urate crystal phagocytosis by polymorphonuclear leukocytes and the effects of colchicine. In: Phagocytic Mechanisms in Health and Disease (eds.: R. C. Williams, H. H. Fudenberg), pp. 107–122. Stuttgart: Georg Thieme 1972
Malawista, S. E.: Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects. Arthritis Rheum. 11, 191–197 (1968)
Malawista, S. E.: The action of colchicine in acute gouty arthritis. Arthritis Rheum. 18 (Suppl.) 835–846 (1975)
Malawista, S. E., Andriole, V. T.: Colchicine: anti-inflammatory effect of low doses in a sensitive bacterial system. J. Lab. Clin. Med. 72, 933–942 (1968)
Malawista, S. E., Bensch, K. G.: Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine. Science 156, 521–522 (1967)
Mamou, H.: La Maladie Périodique. Paris: Expansion Sci. Fr. 1956
Marmont, A. M., Damasio, E. E.: Clinical experiences with cy to toxic immunosuppressive treatment of idiopathic thrombocytopenic purpura. Acta Haematol. 46, 74–91 (1971)
Martin, J., Mainwaring, D.: Coma and convulsions associated with vincristine therapy. Brit. Med. J. 4, 782 (1973)
Mathé, G., Kenis, Y.: La Chimiothérapie des Cancers (Leucémies, Hématosarcomes et Tumeurs Solides), 3rd ed. Paris: Expansion Sci. Fr. 1975
Meriwether, W. D.: Vincristine toxicity with hyponatremia and hypochloremia in an adult. Oncology 25, 234–238 (1971)
Minor, P. D., Roscoe, D. H.: Colchicine resistance in mammalian cell line. J. Cell Sci. 17, 381–396 (1975)
Montaldi, D. H., Giambrone, J. P., Courey, N. G., Taefi, P.: Podophyllin poisoning associated with the treatment of condyloma acuminatum: a case report. Am. J. Obst. Gyn. 119, 1130 (1974)
Nagaratnam, N., de Silva, D. P. K. M., de Silva, N.: Colchicine poisoning following ingestion of Gloriosa superba tubers. Trop. Geograph. Med. 25, 15–17 (1973)
Nicholson, R. G., Feldman, W.: Hyponatremia in association with vincristine therapy. Canad. Med. Ass. J. 106, 356–357 (1972)
O’Callaghan, M. J., Ekert, H.: Vincristine toxicity unrelated to dose. Arch. Dis. Childh. 51, 289–292 (1976)
Oldham, R. K., Pomeroy, T. C.: Vincristine-induced syndrome of inappropriate secretion of antidiuretic hormone. South. Med. J. 65, 1010–1012 (1972)
Oliver, J. M.: Defects in cyclic GMP generation and microtubule assembly in Chediak-Higashi and malignant cells. In: Microtubules and Microtubule Inhibitors (eds.: M. Borgers, De Brabander), pp. 341–354. Oxford-Amsterdam: North-Holland 1975
Oliver, J. M.: Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome. Am. J. Path. 85, 395–418 (1976)
Oliver, J. M., Zurier, R. B., Berlin, R. D.: Concanavalin cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice. Nature (London) 253, 471–473 (1975)
Oliver, J. M., Zurier, R. B.: Correlation of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists. Studies in vitro in Man and in vivo in beige mouse. J. Clin. Invest. 57, 1239–1247 (1976)
Peterson, E., Murray, M.: Serial observations in tissue cultures on neurotoxic effects of colchicine. Anat. Rec. 154, 401 (1966)
Pernice, B.: Sulla cariocinesi delle cellule epiteliali e dell’endotelio dei vasi della mucosa dello stomaco e dell’intestino, nelle studio della gastroenterite sperimentale (nell’avvelenamento per colchico). Sicil. Med. 1, 265–279 (1889)
Phelps, P.: Polymorphonuclear leukocyte motility in vitro. III. Possible release of a chemotactic substance following phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 12, 197–211 (1969)
Phelps, P.: Polymorphonuclear leukocyte mobility in vitro. IV. Colchicine inhibition of the formation of chemotactic activity after phagocytosis of urate crystals. Arthritis Rheum. 13, 1–9 (1970)
Phelps, P.: Appearance of chemotactic activity following intra-articular injection of monosodium urate crystals: effect of colchicine. J. Lab. Clin. Med. 76, 622–631 (1970)
Raff, E. C., Brothers, A. J., Raff, R. A.: Microtubule assembly mutant. Nature (London) 260, 615–616 (1976)
Rak, K.: Effect of vincristine on platelet production in mice. Brit. J. Haematol. 22, 617–624 (1972)
Reimann, H. A.: Periodic disease. A probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. J. Am. Med. Ass. 136, 239–244 (1948)
Reimann, H. A.: Colchicine for periodic peritonitis. J. Am. Med. Ass. 231, 64–66 (1975)
Reiquam, C. W., Prosper, J. C.: Chronic idiopathic thrombocytopenia: treatment with prednisone, 6-mercaptopurine, vincristine, and fresh plasma transfusions. J. Pediatr. 68, 885–889 (1966)
Robbins, E., Gonatas, N.: Histochemical and ultrastructural studies on HeLa cultures exposed to spindle inhibitors with special reference to the interphase cell. J. Histochem. Cytochem. 12, 704 (1964)
Robertson, G. L., Bhoopalam, N., Zelkowitz, L. J.: Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch. Intern. Med. 132, 717–722 (1973)
Robertson, J. H., Crozier, E. H., Woodend, B. E.: The effect of vincristine on the platelet count in rats. Brit. J. Haematol. 19, 331–337 (1970)
Robertson, J. H., Crozier, E. H., Woodend, B. E.: Vincristine-induced thrombocytosis studied with 75Se selenomethionine. Acta Haematol. 47, 356–360 (1972)
Rojkind, M., Kershenobich, D.: Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices. Bioch. Biophys. Acta 378, 415–423 (1975)
Rojkind, M., Uribe, M., Kershenobich, D.: Colcnicine and the treatment of liver cirrhosis. Lancet I, 38–39 (1973)
Rosenthal, S., Kaufman, S.: Vincristine neurotoxicity. Ann. Intern. Med. 80, 733–737 (1974)
Sandier, S. G., Tobin, W., Henderson, E. S.: Vincristine-induced neuropathy: a clinical study of fifty leukemic patients. Neurology 19, 367–374 (1969)
Sartorelli, A. C., Johns, D. G. (eds.): Antineoplastic and immunosuppressive agents, Part. 2. In: Handbuch der experimentellen Pharmakologie (new series) 38/2 (eds.: O. Eichler, A. Farah, H. Herken, A. D. Welch). Berlin-Heidelberg-New York: Springer 1975
Sato, C.: A conditional cell division mutant of Chlamydomonas reinhardii having an increased level of colchicine resistance. Exp. Cell Res. 101, 251–259 (1976)
Schochet, S. S. Jr., Lampert, P. W., Earle, K. M.: Neuronal changes induced by intrathecal vincristine sulfate. J. Neuropathol. Exp. Neurol. 27, 645–658 (1968)
Secret, C. J., Hadfield, J. R., Beer, C. T.: Studies on the binding of (3H) vincristine by rat blood platelets in vitro. Effects of colchicine and vincristine. Biochem. Pharmacol. 21, 1609–1624 (1972)
Selawry, O. S., Holland, J. F., Wolman, I. J.: Effect of vincristine (NSC-67574) on malignant solid tumors in children. Cancer Chem. Rep. 52, 497–500 (1968)
Shelanski, M. L., Wisniewski, H.: Neurofibrillary degeneration induced by vincristine therapy. Arch. Neurol. 20, 199 –206 (1969)
Shirahama, T., Cohen, A. S.: Ultrastructural evidence for leakage of lysosomal contents after phagocytosis of monosodium urate crystals: a mechanism of gouty inflammation. Am. J. Path. 76, 501–520 (1974)
Shirahama, T., Cohen, A. S.: Blockage of amyloid induction by colchicine in an animal model. J. Exp. Med. 140, 1102–1107 (1974)
Slater, L. M., Wainer, R. A., Serpick, A. A.: Vincristine neurotoxicity with hyponatremia. Cancer 23, 122–125 (1969)
Slonim, R. R., Howell, D. S., Brown, H. E. Jr.: Influence of griseofulvin upon acute gouty arthritis. Arthritis Rheum. 5, 397–404 (1962)
Stemmermann, G. N., Hayashi, T.: Colchicine intoxication. A reappraisal of its pathology based on a study of three fatal cases. Human Path. 2, 321–332 (1971)
Stuart, M. J., Cuaso, C., Miller, M., Oski, F. A.: Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. Blood 45, 315–320 (1975)
Sullivan, M. P.: Vincristine (NSC-67574) therapy for Wilms’ tumor. Cancer Chem. Rep. 52, 481–484 (1968)
Suskind, R. M., Brusilow, S. W., Zehr, J.: Syndrome of inappropriate secretion of antidiuretic hormone by vincristine toxicity (with bioassay of ADH level). J. Pediatr. 81, 90–91 (1972)
Terry, R. D.: Neuronal fibrous protein in human pathology. J. Neuropath. Exp. Neurol. 30, 8–19 (1971)
Tobin, W., Sandier, S. G.: Neurophysiologic alterations induced by vincristine (NSC-67574) Cancer Chem. Rep. 52, 519–526 (1968)
Valeriote, F., van Putten, L.: Proliferation-independent cytotoxicity of anticancer agents: a review. Cancer Res. 35, 2619–2630 (1975)
Wakem, C. J., Bennett, J. M.: Inappropriate ADH secretion associated with massive vincristine overdosage. Aust. N. Zeal J. Med. 5, 266–269 (1975)
Wallace, S. L.: Trimethylcolchicinic acid in the treatment of acute gout. Ann. Intern. Med. 54, 274–279 (1961)
Wallace, S. L.: Colchicine and new antiinflammatory drugs in the treatment of gout. Arthritis Rheum. 18 (Suppl.) 847–852 (1975)
Wallace, S. L., Bernstein, D., Diamond, H.: Diagnostic value of the colchicine therapeutic trial. J. Am. Med. Ass. 199, 525–528 (1967)
Wallace, S. L., Ertel, N. H.: Preliminary report: Plasma levels of colchicine after oral administration of a single dose. Metabolism 22, 749–754 (1973)
Wallace, S. L., Nissen, A. W.: Griseofulvin in acute gout. New Engl. J. Med. 266, 1099 to 1101 (1962)
Weiss, H. D., Walker, M. D., Wiernik, P. H.: Neurotoxicity of commonly used antineoplastic agents. New Engl. J. Med. 291, 75–81; 127–133 (1974)
Whittaker, J. A., Parry, D. H., Bunch, C., Weatherall, D. J.: Coma associated with vincristine therapy. Brit. Med. J. 10, 335–336 (1973)
Wisniewski, H., Karczewski, W., Wisniewska, K.: Neurofibrillary degeneration of nerve cells after intracerebral injection of aluminium cream. Acta Neuropathol. 6, 211–219 (1966)
Wisniewski, H., Shelanski, M. L., Terry, R. D.: Experimental colchicine encephalopathy. I. Induction of neurofibrillary degeneration. Lab. Invest. 17, 577–587 (1967)
Wisniewski, H., Terry, R. D.: An experimental approach to the morphogenesis of neurofibrillary degeneration and the argyrophilic plaque. In: Alzheimer’s Disease and Related Conditions (eds.: G. E. W. Wolstenholme, M. O’Connor), pp. 223–240. London: Churchill 1970
Wisniewski, Terry, R. D.: Neurofibrillary pathology. J. Neuropath. Exp. Neurol. 19, 163–176 (1970)
Zbinden, G., Hégélé, M., Grimm, L.: Toxicological effects of vincristine sulfate on blood platelets. Agents and Actions 2, 241–245 (1972)
Zemer, D., Revach, M., Pras, M., Modan, B., Schor, S., Sohar, E., Gafni, J.: Colchicine to prevent attacks of familial Mediterranean fever. New Engl. J. Med. 291, 932–933 (1974)
Zurier, R. B., Weissmann, G., Hoffstein, S.: Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J. Clin. Invest. 53, 297–309 (1974)
Zweig, M. H., Maling, H. M., Webster, M. E.: Inhibition of sodium urate-induced rat hindpaw edema by colchicine derivatives: correlation with antimitotic activity. J. Pharmacol. Exp. Ther. 182, 344–350 (1972)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Dustin, P. (1978). Pathology and Medicine. In: Microtubules. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96436-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-96436-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-96438-1
Online ISBN: 978-3-642-96436-7
eBook Packages: Springer Book Archive